Big Rock Partners Acquisition (Unit)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BRPAU and buy or sell other stocks, ETFs, and their options commission-free!About BRPAU
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt, MD
CEOJonathan C. Javitt, MD
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
BRPAU Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-67.23
Price-Earnings ratio-67.23
Dividend yield—
Dividend yield—
Average volume36.10
Average volume36.10
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$89.00
52 Week high$89.00
52 Week low$10.20
52 Week low$10.20
Stock Snapshot
The current Big Rock Partners Acquisition (Unit)(BRPAU) stock price is $40.00, with a market capitalization of 1.11B. The stock trades at a price-to-earnings (P/E) ratio of -67.23.
On 2025-12-19, Big Rock Partners Acquisition (Unit)(BRPAU) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 36.1.
The stock's 52-week range extends from a low of $10.20 to a high of $89.00.
The stock's 52-week range extends from a low of $10.20 to a high of $89.00.